Irwin Chaiken

机构：Drexel University · ORCID：0000-0002-2996-2030

发表论文 296 篇 · 总被引 9354 次 · h-index 48

代表论文

• The Case for S2: The Potential Benefits of the S2 Subunit of the SARS-CoV-2 Spike Protein as an Immunogen in Fighting the COVID-19 Pandemic (2021 · Frontiers in Immunology · 被引 131)
• Injectable Granular Hydrogels Enable Avidity-Controlled Biotherapeutic Delivery (2024 · ACS Biomaterials Science & Engineering · 被引 22)
• Adenosine deaminase augments SARS-CoV-2 specific cellular and humoral responses in aged mouse models of immunization and challenge (2023 · Frontiers in Immunology · 被引 13)
• Irreversible Inactivation of SARS-CoV-2 by Lectin Engagement with Two Glycan Clusters on the Spike Protein (2023 · Biochemistry · 被引 12)
• Peptide Triazole Inhibitors of HIV-1: Hijackers of Env Metastability (2022 · Current Protein and Peptide Science · 被引 9)
• Improved Durability to SARS-CoV-2 Vaccine Immunity following Coimmunization with Molecular Adjuvant Adenosine Deaminase-1 (2022 · The Journal of Immunology · 被引 7)